Global Triptorelin Acetate Market Production and Consumption Reports 2018

This report studies the global Triptorelin Acetate market status and forecast, categorizes the global Triptorelin Acetate market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appropriate, as well as early onset puberty and female infertility (in vitro fertilisation).

The global production of triptorelin acetate is about 2770 k units in 2015, the production region is mainly concentrated in Europe, the biggest three countries are France, Germany and Ireland. The top two companies are Ipsen and Ferring, they occupies about 95% market shares;

Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption Europe is about 38%, the North America consumes about 12% market share, China occupies about 9% market share, Japan occupies about 8.29% market share.

The production and consumption region is different, the production region is mainly concentrated in Europe, the consumption region is dispersion in all over the world; the countries which do not include in the Europe mainly depends on import.

The global Triptorelin Acetate market is valued at 460 million US$ in 2017 and will reach 620 million US$ by the end of 2025, growing at a CAGR of 3.9% during 2018-2025.

Request Sample Copy of Report @ https://www.qyresearch.com/sample-form/form/81739/global-triptorelin-acetate-market

The major manufacturers covered in this report

Ipsen

Ferring

Chengdu Tiantaishan

TECNOFARMA

Changchun Gensci

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

North America

Europe

China

Japan

Southeast Asia

India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

0.1 mg

3 mg

11.25 mg

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Male Disease

Female Disease

Benefits of Purchasing QY Research Report
• Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
• Customer’s Satisfaction: Our expert team will assist with all your research needs and customize the report
• Inimitable Expertise: Analysts will provide deep insights about the reports
• Assured Quality: We focus on the quality and accuracy of the report

Buy Full Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/503ca7c7d193ce7c620126a01ba02e94,0,1,Global%20Triptorelin%20Acetate%20Market%20Research%20Report%202018

About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

This release was published on openPR.